Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Publication ,  Journal Article
Marwick, TH; Amann, K; Bangalore, S; Cavalcante, JL; Charytan, DM; Craig, JC; Gill, JS; Hlatky, MA; Jardine, AG; Landmesser, U; Newby, LK ...
Published in: Kidney Int
October 2019

Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral annular and aortic valve calcifications are highly prevalent in CKD patients and commonly lead to valvular stenosis and regurgitation, as well as complications including conduction system abnormalities and endocarditis. VHD, especially mitral regurgitation and aortic stenosis, is associated with significantly reduced survival among CKD patients. Knowledge related to VHD in the general population is not always applicable to CKD patients because the pathophysiology may be different, and CKD patients have a high prevalence of comorbid conditions and elevated risk for periprocedural complications and mortality. This Kidney Disease: Improving Global Outcomes (KDIGO) review of CKD and VHD seeks to improve understanding of the epidemiology, pathophysiology, diagnosis, and treatment of VHD in CKD by summarizing knowledge gaps, areas of controversy, and priorities for research.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

October 2019

Volume

96

Issue

4

Start / End Page

836 / 849

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Risk Factors
  • Renal Insufficiency, Chronic
  • Prevalence
  • Mitral Valve Stenosis
  • Mitral Valve Insufficiency
  • Mitral Valve
  • Humans
  • Endocarditis
  • Congresses as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marwick, T. H., Amann, K., Bangalore, S., Cavalcante, J. L., Charytan, D. M., Craig, J. C., … Conference Participants, . (2019). Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 96(4), 836–849. https://doi.org/10.1016/j.kint.2019.06.025
Marwick, Thomas H., Kerstin Amann, Sripal Bangalore, João L. Cavalcante, David M. Charytan, Jonathan C. Craig, John S. Gill, et al. “Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Kidney Int 96, no. 4 (October 2019): 836–49. https://doi.org/10.1016/j.kint.2019.06.025.
Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 Oct;96(4):836–49.
Marwick, Thomas H., et al. “Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Kidney Int, vol. 96, no. 4, Oct. 2019, pp. 836–49. Pubmed, doi:10.1016/j.kint.2019.06.025.
Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ, Conference Participants. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 Oct;96(4):836–849.
Journal cover image

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

October 2019

Volume

96

Issue

4

Start / End Page

836 / 849

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Risk Factors
  • Renal Insufficiency, Chronic
  • Prevalence
  • Mitral Valve Stenosis
  • Mitral Valve Insufficiency
  • Mitral Valve
  • Humans
  • Endocarditis
  • Congresses as Topic